Skip to main content

OPINION article

Front. Med., 25 November 2021
Sec. Infectious Diseases – Surveillance, Prevention and Treatment
Volume 8 - 2021 | https://doi.org/10.3389/fmed.2021.706794

Artificial Intelligence (AI) and Lung Ultrasound in Infectious Pulmonary Disease

Guglielmo Trovato* Matteo Russo*
  • The European Medical Association (EMA), Brussels, Belgium

Summary

Deep Learning algorithms are ready for use and can aid in the interpretation of radiological findings monitoring change during follow-up. However, the translational approach to ultrasound is difficult and currently subject to major limitations. Great help can derive from computer-assisted report procedures, which, in appropriate contexts of expert machine learning, can structure a future context of diagnostic orientation.

Lung ultrasound is a diagnostic method that relies heavily on the operator's abilities, in which the human expertise component must be accompanied by the most suitable quality of the equipment and of its appropriate setting. However, this strictly clinical and qualitative interpretation when reading lung images is an element of weakness since we have health professionals with different levels of knowledge and expertise in performing the procedure. There are also particular difficulties linked to the conditions of the patients and to the methods of assistance and caution due to the need to prevent contagion in the fight against coronavirus 2019 disease (COVID-19).

Patients, particularly in limited resource subsets at home, in ambulances, and in emergency room facilities, are very difficult subjects even for expert operators, and this is also because chest ultrasounds are full-contact procedures.

Quantitative analysis makes radiology reporting much more comprehensive. Actually, several research groups have begun looking to artificial intelligence (AI) as a tool for reading and analyzing X-rays and computed tomography (CT) scans and helping to diagnose and monitor COVID-19 by several deep-learning approaches. This is carried out with the hope of overcoming the intrinsic limits of the diagnostic procedure and the context of intervention.

Unfortunately, with US procedures, the proposal to use inappropriate methods, based on the automatic reading of the artifacts, in particular of the b-lines, has been addressed: this is what has been unexpectedly, and for no good reason, suggested by many. In this regard, it must be strongly reiterated that quantifying erratic and unreliable artifacts, measuring them by machine counting methods, is only a mystifying and misleading approach without advantages and is de facto dangerous in patient management.

Currently, it is unlikely that the algorithms proposed may directly replace the medical doctors, and, namely, the radiologists' judgments as well as personal responsibility during ultrasound diagnosis. This is due to the limited or even absent specificity of these approaches for categorizing definite findings and to the medico-legal implications of such diagnoses.

Overview

Research, development, application, and dissemination of Artificial Intelligence (AI) in imaging and vision techniques can allow us to gather a great deal of complex information as well as provide very direct diagnoses from available data. Current computer vision techniques powered by deep learning for medical applications have their focus on medical imaging, medical videos, and clinical deployment (1). A still unresolved challenge is that clinical workflows, encompassing different sources and features of data, should integrate computer vision to enhance medical practice and health care. Currently, several research groups have begun looking to artificial intelligence (AI) as a tool for reading and analyzing X-rays and computed tomography (CT) scans, helping to diagnose and monitor COVID-19 by several deep-learning approaches. Lung ultrasound is a diagnostic method greatly operator-dependent, in which the human expertise component must be accompanied by the most suitable quality of the equipment and its appropriate setting (2). As a consequence, this strictly clinical and qualitative interpretation reading of lung images is an element of weakness when health professionals with different levels of knowledge and expertise in performing the procedure are operating (3). Patients, particularly in limited resource subsets at home, in ambulances, and in emergency room facilities, are very difficult subjects for a full-contact procedure such as the chest ultrasound. Specific difficulties are related to the clinical conditions of the patients and to the methods of assistance and caution due to the need to prevent the spread of infection in the fight against coronavirus disease 2019 (COVID-19). This makes it even more difficult to perform the exam (4, 5). The extent of the lung ultrasound (LUS) was an important factor in the diagnosis of COVID-19 pulmonary involvement, and it is still widely debated today, especially with regard to the differential diagnosis between different pathologies (6). Indeed, the point is that chest ultrasound does result in false negatives in most cases, even when performed with a great level of expertise and scrutiny (6). Overall, Lung Ultrasound (LUS) should not be considered as a reliable imaging tool in ruling out COVID-19 pneumonia in any patient, in Emergency or elective subsets. This is demonstrated according to unbiased experience and accurate assessment of actual achievements (6). The US method of lung imaging, especially in the diagnosis of pneumonia, whatever its cause, including COVID-19, finds its application role in the integration of other more sensitive and specific diagnostic tests, such as the nasopharyngeal swab, virus molecular assays, and Chest-CTs.

Crossing and Overlapping

Are there any cross points or overlaps between radiological profile imaging, namely, plain chest X-rays (CXR), Computerized Tomography (CT), Nuclear Magnetic Resonance NMR, and Ultra-Sound (US) imaging? Yes, of course. Nonetheless, a brief discussion on how it has been possible to progress with deep learning approaches in the fields of AI vision machinery may still be useful. Medical images have peculiar characteristics, nowadays often already coming from digital signal processing. For these reasons, they represent a series of challenges to machine vision based on deep learning (1). Computer vision in radiology has a greater focus on chest X-ray analysis, a field that has collected millions of annotated, open-source images (7). Such approaches should have enabled the field to respond rapidly in times of crisis, for instance, developing and deploying COVID-19 detection models (8). This area of research and application continues to expand with work in image translation (e.g., striving to convert noisy ultrasound images into Magnetic Resonance Imaging) (1) and with other advances in computational lung ultrasound imaging (9).

Image processing methods may be split into two categories: (1) traditional model-based methods and (2) data-driven methods. For the former, inverse problems are based on methods focusing in particular on ultrasound imaged speckling, deconvolution, and line artifacts detection. For the second method, among the data-driven approaches, various machines, as well as deep learning procedures, have been applied in the contexts of supervised, weakly supervised, and unsupervised learning. These include the implementation of various effective network architectures, in the case of deep learning, and high-dimensional statistical methods in the case of the more traditional machine learning (9). Nonetheless, given that ultrasound images involve operator-, patient-, and scanner-dependent variations, the adaptation of classical machine learning methods to clinical applications becomes challenging, and such challenges still constitute a major limitation in Lung US imaging, even without any automation of interpretation, more if reasonably and unpredictably amplified by digital approaches based on uncertain, erratic and misleading data (10). Differently, in radiology, a deep learning model, the COVID-19 detection neural network (COVNet), was developed to extract visual features from volumetric chest CT scans for the detection of COVID-19. CT scans of community-acquired pneumonia (CAP) and other on-pneumonia abnormalities were included to test the robustness of the model. The conclusion is that such a model accurately detects coronavirus 2019 pulmonary disease and differentiates it from community-acquired pneumonia and other lung conditions (11). Using CX-Rays, even if deep neural networks models are suitable to classify most chest X-ray images into a specified target class, careful consideration is required. Their practical applications to COVID-19 diagnosis are not yet sufficiently safe due to the need for strategies to address security concerns (12). This warning is mostly relevant considering several overenthusiastic reports, claiming a very successful but unlikely application of such methods (13, 14).

Appropriateness and Reliability—Mistaken Proposals

Regarding the appropriateness of the use of automatic digital analyzes in thoracic ultrasound, all the claims of great success have been regularly denied in the medical journals that have published timely articles and comments (1517). In many of our previous detailed comments, the appropriateness of methods based on ultrasound artifacts, that is, on the operator's inability to obtain visible images, was denied. Ultimately, it is like saying that if an inexperienced operator is unable to perform an adequate examination with meaningful images, getting only erratic artifacts, then the pathology is present (18). As a consequence, and certainly much worse, some groups tried to accredit the concept that at greater levels of difficulty in acquiring meaningful images, there are different or more severe pathologies (19). Finally, an attempt has been made to give these approaches, based on the measurement of information lacking any reliability or reproducibility, the role, and rank of objective automated measurements (20, 21). All this has reached the level of unofficial recommendations. Such “guidelines,” under so great inconsistency, can only be considered as mistaken proposals, particularly dangerous when they are aimed at replacing the doctor's action in carrying out the examination, substituting their clinical judgment for a diagnostic evaluation, even among COVID-19 pandemics and emergency referrals (2224).

Clinical Unmet Needs and the Marketplace Reasons

At this point, an analysis of this situation is necessary. What are the unmet needs? Of these, there are too many. The focus is on the search for the advantages of performing an examination on the patient without irradiation risk, being safe with regard to the possibility of inter-human contagion, being performable at the patient's bedside (or in any case in the treatment area), being reproducible in any context and by any operator, and being appropriate for use as a preferential diagnosis with respect to radiological methods. The answer is, unfortunately, that these needs are not met at all either by the thoracic ultrasound that uses images, but still less, by approaches based on the empiricism of erratic tests counting and searching for b-lines, i.e., artifacts due to bad machine settings, unskilled operators, difficult or impossible echographic window, or a melting pot of all concurrent biases (25).

The measurement of chaotic artifacts, which is very dependent on factors not related to the specificity of the pathologies, must be acknowledged as not being the desired solution (26). In an era of managed healthcare, the reasons, interventions, and conflicts present in the marketplace must be taken into consideration (1). However, apart from advertising methods and tools that are claimed to provide answers of excellent diagnostic quality, there is nothing that suggests which improvement in managed health care might currently ensue from a generalized deep learning approach. This should be developed (and has not yet been done) within transparent clinical trials focused on risk analysis and management mitigation plans. Only this will allow avoiding incorrect or delayed diagnosis, which is in fact the only certainty we can hold on to on inconsistent bases, as are currently and sparsely proposed. Optimal approaches, in our view, should be targeted to the training and quality enhancement of single operator skills, knowledge, and interpretation (27).

Conclusion

The proposal to use inappropriate methods, based on the automatic reading of artifacts, namely, of B-lines, has returned unexpectedly, and for no good reason, from many sides, and must be reasonably rejected. In this regard, it must be strongly reiterated that quantifying erratic and unreliable measurements by machine counting methods is only a mystifying and misleading approach, without advantages, and is de facto dangerous in patient management. These beliefs are detrimental for the other best-supported ultrasound practices in any subset, including emergency and pediatrics (28, 29). Lung ultrasound allows detecting lung consolidations in many patients with CXR-confirmed Community-Acquired Pneumonia, even giving, regretfully, false-negative results in a quarter of cases. Previous longitudinal results confirm its role in the follow-up of detectable lesions. Nonetheless, ultrasound should be regarded only as a complementary and monitoring tool in pneumonia, instead of a primary imaging modality (30).

The claims of lung ultrasound usefulness in COVID-19 pneumonia are unsupported. Namely, it should not be considered an alternative to CT scan for assessment of COVID-19 pneumonia in pregnant women, especially considering the higher risk of operator exposure to contagion associated with this type of examination (31). Moreover, Lung US findings in COVID-19 patients are even less specific than those detectable on CT scans are (32).

Deep Learning algorithms can aid in the interpretation of radiological findings and may help for monitoring their change over follow-up. However, the translational approach to ultrasound is intrinsically difficult, lacks any evidence basis, and is currently still subject to major limitations. Great help can be derived from computer-assisted report procedures, which, in appropriate contexts of expert machine learning, can structure a future more harmonic context of shared diagnostic orientation. Currently, it is unlikely that the algorithms proposed may directly replace the medical doctors', and, namely, the radiologist's, judgment and responsibility in ultrasound diagnoses. This is due to the limited or absent specificity of these approaches for categorizing specific findings and to the medico-legal implications of such diagnosis. Requirements regarding certifiability of AI approaches and applications are of utmost relevance (Table 1) and far from being currently achieved in Lung US imaging.

TABLE 1
www.frontiersin.org

Table 1. Requirements for a suitable use of deep learning in Lung imaging: what the lung ultrasound still lacks. Key messages.

Author Contributions

All authors listed have made a substantial, direct and intellectual contribution to the work, and approved it for publication.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

1. Esteva A, Chou K, Yeung S, Naik N, Madani A, Mottaghi A, et al. Deep learning-enabled medical computer vision. NPJ Digit Med. (2021) 4:5. doi: 10.1038/s41746-020-00376-2

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Sperandeo M, Rotondo A, Guglielmi G, Catalano D, Feragalli B, Trovato GM. Transthoracic ultrasound in the assessment of pleural and pulmonary diseases: use and limitations. Radiol Med. (2014) 119:729–40. doi: 10.1007/s11547-014-0385-0

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Sperandeo M, Trovato GM. Lung ultrasound early detection and monitoring in COVID-19 pneumonia: fact and fiction. QJM. (2020) 113:601–2. doi: 10.1093/qjmed/hcaa165

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Sperandeo M, Trovato G. Lung ultrasound in COVID-19 patients - more shadows than information. Ultraschall Med. (2020) 41:439–40. doi: 10.1055/a-1177-3156

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Quarato CMI, Venuti M, Sperandeo M. Diagnosis of coronavirus disease (COVID-19) pneumonia: is lung ultrasound the better choice? AJR Am J Roentgenol. (2021) 216:W5. doi: 10.2214/AJR.20.24538

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Quarato CMI, Mirijello A, Lacedonia D, Russo R, Maggi MM, Rea G, et al. low sensitivity of admission lung us compared to chest CT for diagnosis of lung involvement in a cohort of 82 patients with COVID-19 pneumonia. Medicina (Kaunas). (2021) 57:236. doi: 10.3390/medicina57030236

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Rajpurkar P, Irvin J, Ball RL, Zhu K, Yang B, Mehta H, et al. Deep learning for chest radiograph diagnosis: a retrospective comparison of the CheXNeXt algorithm to practicing radiologists. PLoS Med. (2018) 15:e1002686. doi: 10.1371/journal.pmed.1002686

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Zhang J, Xie Y, Pang G, Liao Z, Verjans J, Li W, et al. Viral pneumonia screening on chest X-rays using confidence-aware anomaly detection. IEEE Trans Med Imaging. (2021) 40:879–90. doi: 10.1109/TMI.2020.3040950

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Yang T, Karakuş O, Anantrasirichai N, Achim A. Current advances in computational lung ultrasound imaging: a review. arXiv preprint. (2021). arXiv:2103.11366.

Google Scholar

10. Akkus Z, Cai J, Boonrod A, Zeinoddini A, Weston AD, Philbrick KA, et al. A survey of deep-learning applications in ultrasound: artificial intelligence-powered ultrasound for improving clinical workflow. J Am Coll Radiol. (2019) 16:1318–28. doi: 10.1016/j.jacr.2019.06.004

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Li L, Qin L, Xu Z, Yin Y, Wang X, Kong B, et al. Using artificial intelligence to detect COVID-19 and community-acquired pneumonia based on pulmonary ct: evaluation of the diagnostic accuracy. Radiology. (2020) 296:E65–71. doi: 10.1148/radiol.2020200905

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Hirano H, Koga K, Takemoto K. Vulnerability of deep neural networks for detecting COVID-19 cases from chest X-ray images to universal adversarial attacks. PLoS ONE. (2020) 15:e0243963. doi: 10.1371/journal.pone.0243963

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Hurt B, Kligerman S, Hsiao A. Deep Learning Localization of Pneumonia: 2019 Coronavirus (COVID-19) Outbreak. J Thorac Imaging. (2020) 35:W87–9. doi: 10.1097/RTI.0000000000000512

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Oh Y, Park S, Ye JC. Deep learning COVID-19 features on CXR using limited training data sets. IEEE Trans Med Imaging. (2020) 39:2688–700. doi: 10.1109/TMI.2020.2993291

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Rea G, Trovato GMA. Farewell to B-lines: ageing and disappearance of ultrasound artifacts as a diagnostic tool. Respiration. (2015) 90:522. doi: 10.1159/000441010

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Trovato GM, Sperandeo M. Usefulness of lung ultrasound imaging in COVID-19 pneumonia: The persisting need of safety and evidences. Echocardiography. (2020) 37:1138–9. doi: 10.1111/echo.14769

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Trovato GM, Sperandeo M. The resistible rise of B-line lung ultrasound artefacts. Respiration. (2015) 89:175–6. doi: 10.1159/000369037

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Trovato GM, Catalano D, Sperandeo M, Graziano P. Artifacts, noise and interference: much ado about ultrasound. Respiration. (2015) 90:85. doi: 10.1159/000375316

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Trovato GM, Catalano D, Sperandeo M. Assessment of lung ultrasound artifacts (B-lines): incremental contribution to echocardiography in heart failure? JACC Cardiovasc Imaging. (2014) 7:635. doi: 10.1016/j.jcmg.2013.11.013

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Trovato GM, Catalano D, Martines GF, Sperandeo M. Is it time to measure lung water by ultrasound? Intensive Care Med. (2013) 39:1662. doi: 10.1007/s00134-013-2965-1

PubMed Abstract | CrossRef Full Text | Google Scholar

21. Sperandeo M, Trovato GM, Catalano D. Quantifying B-lines on lung sonography: insufficient evidence as an objective, constructive, and educational tool. J Ultrasound Med. (2014) 33:362–5. doi: 10.7863/ultra.33.2.362

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Trovato GM, Sperandeo M, Catalano D. Computed tomography screening for lung cancer. Ann Intern Med. (2013) 159:155. doi: 10.7326/0003-4819-159-2-201307160-00016

PubMed Abstract | CrossRef Full Text | Google Scholar

23. Trovato GM, Sperandeo M. Sounds, ultrasounds, and artifacts: which clinical role for lung imaging? Am J Respir Crit Care Med. (2013) 187:780–1. doi: 10.1164/ajrccm.187.7.780

PubMed Abstract | CrossRef Full Text | Google Scholar

24. Sperandeo M, Trovato GM. Care of future mothers amid the COVID-19 outbreak: is there a monitoring role for lung ultrasound? Ultrasound Obstet Gynecol. (2020) 56:469–70. doi: 10.1002/uog.22146

PubMed Abstract | CrossRef Full Text | Google Scholar

25. Trovato FM, Musumeci G. Lung ultrasound: the need of an adequate training for the next generation of internists. Neth J Med. (2015) 73:305.

PubMed Abstract | Google Scholar

26. Interrigi MC, Trovato FM, Catalano D, Trovato GM. Emergency thoracic ultrasound and clinical risk management. Ther Clin Risk Manag. (2017) 13:151–60. doi: 10.2147/TCRM.S126770

PubMed Abstract | CrossRef Full Text | Google Scholar

27. Sperandeo M, Rea G, Grimaldi MA, Trovato F, Dimitri LM, Carnevale V. Contrast-enhanced ultrasound does not discriminate between community acquired pneumonia and lung cancer. Thorax. (2017) 72:178–80. doi: 10.1136/thoraxjnl-2016-208913

PubMed Abstract | CrossRef Full Text | Google Scholar

28. Trovato FM, Catalano D, Trovato GM. Thoracic ultrasound: An adjunctive and valuable imaging tool in emergency, resource-limited settings and for a sustainable monitoring of patients. World J Radiol. (2016) 8:775–84. doi: 10.4329/wjr.v8.i9.775

PubMed Abstract | CrossRef Full Text | Google Scholar

29. Trovato FM, Catalano D. Diagnosis of pneumonia by lung ultrasound in children and limited resources subsets: a valuable medical breakthrough. Chest. (2016) 150:258–60. doi: 10.1016/j.chest.2016.04.032

PubMed Abstract | CrossRef Full Text | Google Scholar

30. D'Amato M, Rea G, Carnevale V, Grimaldi MA, Saponara AR, Rosenthal E, et al. Assessment of thoracic ultrasound in complementary diagnosis and in follow up of community-acquired pneumonia (cap). BMC Med Imaging. (2017) 17:52. doi: 10.1186/s12880-017-0225-5

PubMed Abstract | CrossRef Full Text | Google Scholar

31. Quarato CMI, Venuti M, Lacedonia D, Simeone A, Sperandeo M. Diagnosis and monitoring of COVID-19 pneumonia in pregnant women: is lung ultrasound appropriate? Ultrasound Obstet Gynecol. (2020) 56:467–8. doi: 10.1002/uog.22156

PubMed Abstract | CrossRef Full Text | Google Scholar

32. Lacedonia D, Quarato CMI, Mirijello A, Trovato GM, Del Colle A, Rea G, et al. COVID-19 pneumonia: the great ultrasonography mimicker. Front Med (Lausanne). (2021) 8:709402. doi: 10.3389/fmed.2021.709402

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: artificial intelligence, deep learning-artificial neural network (DL-ANN), ethics, lung imaging, bullying in international settings

Citation: Trovato G and Russo M (2021) Artificial Intelligence (AI) and Lung Ultrasound in Infectious Pulmonary Disease. Front. Med. 8:706794. doi: 10.3389/fmed.2021.706794

Received: 08 May 2021; Accepted: 01 November 2021;
Published: 25 November 2021.

Edited by:

Yoav Keynan, University of Manitoba, Canada

Reviewed by:

Ronald Balczon, University of South Alabama, United States
Yuetian Yu, Shanghai JiaoTong University, China

Copyright © 2021 Trovato and Russo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Guglielmo Trovato, trovato.eu@gmail.com; Matteo Russo, russo.matteo0801@gmail.com

Download